Markets
Wall Street 2026 outlook and S&P 500 forecasts (binoculars)
(CSA Archive/Getty Images)

Wall Street has great expectations for the next year in the stock market

Stock watchers are pretty bullish about the coming year — as they typically are — with eyes on the Fed and whether the AI boom will still have legs. BofA is a little skeptical.

With end-of-year outlooks largely in — Bank of America equity analysts dropped theirs Tuesday — we figured it was worth taking stock of the prognostications from some of Wall Street’s more high-profile equity strategy shops.

True to form, these professional market watchers are bullish. Not shocking, considering the institutional biases of those employed by the securities industry — and the fact that the stock market usually does rise.

More interesting are the rationales for their projections, which largely center on two key issues facing investors and traders: the paths forward for the AI investment boom and the Federal Reserve.

Deutsche Bank equity strategists see the largest jump, thanks to a combination of robust earnings growth in 2026 and price-to-earnings multiples that they expect to stay near some of the most elevated levels we’ve seen since the dot-com boom of the late 1990s.

“We expect multiples to sustain if not push higher against the backdrop of a robust demand-supply balance for equities,” Deutsche Bank analysts captained by Binky Chadha wrote.

Morgan Stanley analysts are only slightly less optimistic, writing in their outlook — issued in the middle of November — that another factor that may keep valuations elevated will come from easier monetary policy than is currently baked into the market prices. (For more on how the Fed and interest rates affect valuations, read this.)

“We think that moderate weakness in lagging labor data and the administration’s desire to ‘run it hot’ will lead to an accommodative monetary policy backdrop involving both rates and the balance sheet,” wrote MS analysts led by Mike Wilson.

RBC equity analysts, led by Lori Calvasina, also see a helpful hand coming from expected Federal Reserve rate cuts.

“Fighting the Fed doesn’t make sense,” they wrote, adding that “historically, when the Fed has made modest cuts in a
12-month period that amount to 1% or less, the S&P 500 has gone up by 13.3% on average during that same time period.”

JPMorgan’s call for the index rising to 7,500 next year likewise hinges on the US central bank.

In the report, written by Dubravko Lakos-Bujas and team, they say that view “is anchored on our JPM Economics view of two more cuts followed by an extended pause. However, should the Fed ease policy further (due to improving inflation dynamics), we see greater upside with the S&P 500 surpassing 8,000 in 2026.”

Goldman Sachs’ team of analysts led by Peter Oppenheimer who see the S&P 500 at 7,600 next year — likewise think high price-to-earnings multiples might actually now be normal, reflecting lower interest rates and higher earnings.

“While valuations are very high today relative to history, multiples have generally trended higher during the last several decades,” they wrote. “This trend can largely be explained by the trend lower in interest rates and higher in corporate profitability.”

AI air pocket ahead?

Rivaling the Fed as an analytical input is the path forward for the AI investment boom that’s been driving both the economy and the markets this year.

HSBC analysts led by Nicole Inui think another year of high-flying gains could be in the cards, partly driven by continued big spending from hyperscalers.

“Our base case is for the Fed to remain on hold, the economy to slow but remain resilient as AI capex spend accelerates, and earnings growth to maintain a double-digit pace — buoyed by tech and AI but also broadening to other sectors benefiting from AI spend, adoption, and easier comps,” they wrote.

Likewise, Venu Krishna and colleagues at Barclays (target of 7,400 in ’26) predict the “AI story keeps rolling, despite recent volatility sparked by capex and financing concerns, as compute demand continues to scale and monetization grows to encapsulate paid users, ads, and enterprise/agents.”

On the less bullish side, Savita Subramanian’s team of stock analysts at Bank of America sees more lackluster results in 2026, after three sizzling years of market gains led by megacap tech companies.

“On AI, in our view, investors should get ready for an air pocket. Monetization is to be determined (TBD) and power is the bottle neck and will take a while to build out,” they wrote, adding that “for now investors are buying the dream.”

More Markets

See all Markets
markets

With their recent surge, Intel shares just hit their highest level since the dot-com era

Intel’s surge of nearly 60% this month has the iconic American chipmaker’s stock price approaching levels last seen during the dot-com era. Bloomberg noted that shares just touched their highest intraday level since the turn of the century:

The stock rose as much as 1.5% to $69.55, topping a peak it hit on Jan. 24, 2020. The shares are up 90% this year, after soaring 84% in 2025. Intel is now roughly 8% from its all-time closing high of $74.88, established on Aug. 31, 2000.

That’s just the most recent late-’90s-era throwback we’ve been seeing in tech shares lately. Oracle is currently pacing for its best week since late 1999.

What’s even more remarkable, however, is that Intel’s forward price-to-earnings ratio today dwarfs the premiums the market was putting on the stock during the nuttiness of the dot-com mania.

That reflects the fact that the recent run-up in Intel shares is, essentially, giving the chip giant credit for a massive turnaround that hasn’t actually happened yet.

One also might wonder if the fact that Intel is partially owned by the US government means it’s more attractive — and therefore worth a higher premium — than other chipmakers without the state imprimatur.

Still, kind of startling.

markets

Eli Lilly’s GLP-1 pill hit nearly 1,400 prescriptions in first week

Eli Lilly rose after preliminary numbers cited by Wall Street analysts showed strong uptake of its new weight-loss pill.

The FDA approved Foundayo on April 1 and shipments began on April 9. In its first week, roughly 1,400 US prescriptions were written for the drug, according to IQVIA data cited by Deustche Bank analysts in a Friday note.

Novo Nordisk, Lilly’s rival in the GLP-1 market, released its GLP-1 pill earlier this year, and early signs show that it’s expanding the market, inviting patients who were turned off by weekly injections. Novo’s pill had a stronger first week than Lilly’s, with its Wegovy pill hitting 3,071 US prescriptions in the first four days after its launch on January 5.

Lilly’s pill has an advantage over Novo’s, which is that it can be taken at any time of day, with or without food. Lilly disclosed in a February regulatory filing that it had $1.5 billion worth of prelaunch inventory ready ahead of the FDA approval — which is about as much as analysts polled by FactSet expect it to sell this year.

Novo Nordisk, Lilly’s rival in the GLP-1 market, released its GLP-1 pill earlier this year, and early signs show that it’s expanding the market, inviting patients who were turned off by weekly injections. Novo’s pill had a stronger first week than Lilly’s, with its Wegovy pill hitting 3,071 US prescriptions in the first four days after its launch on January 5.

Lilly’s pill has an advantage over Novo’s, which is that it can be taken at any time of day, with or without food. Lilly disclosed in a February regulatory filing that it had $1.5 billion worth of prelaunch inventory ready ahead of the FDA approval — which is about as much as analysts polled by FactSet expect it to sell this year.

markets

Critical Metals jumps after Greenland’s government approves CRML to take majority control of the Tanbreez mining project

Critical Metals is up more than 25% in premarket trading on Friday after the critical mining company announced that it now owns 92.5% of the Tanbreez rare earth deposit following an approval from the government of Greenland.

With that latest government support, Critical Minerals added an additional 50.5% stake to its ownership, reportedly acquired from Rimbal Pty Ltd, per Bloomberg News. With access to eight heavy rare earth elements often used in consumer electronics and defense, the site is one of the world’s largest undeveloped rare earth deposits and a key source of rare earth supply outside of China, according to the company.

In Critical Metals’ press release, Chairman Tony Sage commented that the approval “removes the most significant structural overhang on the project and provides the clarity to advance Tanbreez to production with confidence,” especially as Tanbreez’s location offers a significant logistical advantage through its year-round direct shipping access, compared to rival projects.

With 92.5% of the project now vested in Critical Metals Corp., and the remainder owned by European Lithium Ltd., CRML now has full control of the project and is seeking to accelerate development there, with plans for a new international airport and a 150-tonne bulk sample program, which is slated for June 2026.

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, Robinhood Derivatives, LLC, or Robinhood Money, LLC. Futures and event contracts are offered through Robinhood Derivatives, LLC.